Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study

H. G. Nuesslein; R. Alten; M. Galeazzi; H. -M. Lorenz; M. T. Nurmohamed; W. G. Bensen; G. R. Burmester; H. -H. Peter; P. Peichl; K. Pavelka; M. Chartier; C. Poncet; C. Rauch; M. Le Bars

Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study

H. G. Nuesslein, R. Alten, M. Galeazzi, H. -M. Lorenz, M. T. Nurmohamed, W. G. Bensen, G. R. Burmester, H. -H. Peter, P. Peichl, K. Pavelka, M. Chartier, C. Poncet, C. Rauch, M. Le Bars

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	489-499
Journal	Clinical and Experimental Rheumatology
Volume	34
Issue number	3
Publication status	Published - 2016

Cite this

Nuesslein, H. G., Alten, R., Galeazzi, M., Lorenz, H. -M., Nurmohamed, M. T., Bensen, W. G., Burmester, G. R., Peter, H. -H., Peichl, P., Pavelka, K., Chartier, M., Poncet, C., Rauch, C., & Le Bars, M. (2016). Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study. Clinical and Experimental Rheumatology, 34(3), 489-499.

@article{f11bbb6cade548bbbff029945818d54e,

title = "Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study",

keywords = "abatacept, biological therapy, cohort studies, cyclic citrullinated peptide, rheumatoid arthritis, rheumatoid factor",

author = "Nuesslein, {H. G.} and R. Alten and M. Galeazzi and Lorenz, {H. -M.} and Nurmohamed, {M. T.} and Bensen, {W. G.} and Burmester, {G. R.} and Peter, {H. -H.} and P. Peichl and K. Pavelka and M. Chartier and C. Poncet and C. Rauch and {Le Bars}, M.",

year = "2016",

language = "English",

volume = "34",

pages = "489--499",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "3",

}

Nuesslein, HG, Alten, R, Galeazzi, M, Lorenz, H-M, Nurmohamed, MT, Bensen, WG, Burmester, GR, Peter, H-H, Peichl, P, Pavelka, K, Chartier, M, Poncet, C, Rauch, C & Le Bars, M 2016, 'Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study', Clinical and Experimental Rheumatology, vol. 34, no. 3, pp. 489-499.

Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study. / Nuesslein, H. G.; Alten, R.; Galeazzi, M. et al.

In: Clinical and Experimental Rheumatology, Vol. 34, No. 3, 2016, p. 489-499.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study

AU - Nuesslein, H. G.

AU - Alten, R.

AU - Galeazzi, M.

AU - Lorenz, H. -M.

AU - Nurmohamed, M. T.

AU - Bensen, W. G.

AU - Burmester, G. R.

AU - Peter, H. -H.

AU - Peichl, P.

AU - Pavelka, K.

AU - Chartier, M.

AU - Poncet, C.

AU - Rauch, C.

AU - Le Bars, M.

PY - 2016

Y1 - 2016

KW - abatacept

KW - biological therapy

KW - cohort studies

KW - cyclic citrullinated peptide

KW - rheumatoid arthritis

KW - rheumatoid factor

M3 - Article

VL - 34

SP - 489

EP - 499

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3

ER -